79 related articles for article (PubMed ID: 21383301)
1. Development and measurement of guideline-based indicators for patients with non-Hodgkin's lymphoma.
Wennekes L; Ottevanger PB; Raemaekers JM; Schouten HC; de Kok MW; Punt CJ; Grol RP; Wollersheim HC; Hermens RP
J Clin Oncol; 2011 Apr; 29(11):1436-44. PubMed ID: 21383301
[TBL] [Abstract][Full Text] [Related]
2. Guideline-based development of quality indicators for subfertility care.
Mourad SM; Hermens RP; Nelen WL; Braat DD; Grol RP; Kremer JA
Hum Reprod; 2007 Oct; 22(10):2665-72. PubMed ID: 17664242
[TBL] [Abstract][Full Text] [Related]
3. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice].
Faber LM; van Agthoven M; Uyl-de Groot CA; Löwenberg B; Huijgens PC
Ned Tijdschr Geneeskd; 2000 Jun; 144(25):1223-7. PubMed ID: 10897302
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index.
Janssen-Heijnen ML; van Spronsen DJ; Lemmens VE; Houterman S; Verheij KD; Coebergh JW
Br J Haematol; 2005 Jun; 129(5):597-606. PubMed ID: 15916681
[TBL] [Abstract][Full Text] [Related]
6. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
[TBL] [Abstract][Full Text] [Related]
7. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant medication use and non-Hodgkin's lymphoma risk: no association.
Bahl S; Cotterchio M; Kreiger N; Klar N
Am J Epidemiol; 2004 Sep; 160(6):566-75. PubMed ID: 15353417
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
10. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
11. Incidence and survival of gastric non-Hodgkin's lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM).
Danzon A; Belot A; Maynadié M; Remontet L; Dupont AC; Carbonnel F;
Acta Oncol; 2009; 48(7):977-83. PubMed ID: 19551530
[TBL] [Abstract][Full Text] [Related]
12. Variation in subfertility care measured by guideline-based performance indicators.
Mourad SM; Nelen WL; Hermens RP; Bancsi LF; Braat DD; Zielhuis GA; Grol RP; Kremer JA
Hum Reprod; 2008 Nov; 23(11):2493-500. PubMed ID: 18653670
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma: in a class all its own.
Titcomb CP
J Insur Med; 2001; 33(4):329-38. PubMed ID: 11877913
[TBL] [Abstract][Full Text] [Related]
14. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry.
van Spronsen DJ; Janssen-Heijnen ML; Lemmens VE; Peters WG; Coebergh JW
Eur J Cancer; 2005 May; 41(7):1051-7. PubMed ID: 15862755
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice].
Peters FP; Erdkamp FL
Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1752-3. PubMed ID: 10992902
[No Abstract] [Full Text] [Related]
16. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
17. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to non-Hodgkin's lymphoma in the elderly patient.
Ninan MJ; Morrison VA
Expert Rev Hematol; 2009 Apr; 2(2):173-82. PubMed ID: 21083450
[TBL] [Abstract][Full Text] [Related]
19. European experiences on aggressive non-Hodgkin's lymphoma in elderly patients.
Fratino L; Bernardi D
Crit Rev Oncol Hematol; 2004 Sep; 51(3):229-40. PubMed ID: 15331080
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
Lyman GH; Dale DC; Friedberg J; Crawford J; Fisher RI
J Clin Oncol; 2004 Nov; 22(21):4302-11. PubMed ID: 15381684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
